Data / Drug companies / Barbiturate
Barbiturate drugs: 14 drugs from 51 companies in the FDA NDC directory
Barbiturate is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 103 products in this class from 51 companies, covering 14 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on June 9, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 51Companies
- 103Products
- 14Drugs by generic name
Drugs in the Barbiturate class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Butalbital, acetaminophen and caffeine | 37 | 23 |
| Butalbital, acetaminophen, and caffeine | 26 | 22 |
| Butalbital and acetaminophen | 15 | 9 |
| Butalbital, aspirin, and caffeine | 5 | 5 |
| Butalbital, acetaminophen, caffeine and codeine phosphate | 5 | 4 |
| Butalbital, aspirin, caffeine and codeine phosphate | 3 | 3 |
| Methohexital sodium | 3 | 3 |
| Butalbital, acetaminophen, caffeine, and codeine phosphate | 3 | 2 |
| Butal/apap/caff | 1 | 1 |
| Butal/apap/caffeine | 1 | 1 |
| Butalbital and acetaminophen tablets | 1 | 1 |
| Butalbital, acetaminophen, and caffeine capsules | 1 | 1 |
| Butalbital, aspirin, cafeine, and codeine phosphate | 1 | 1 |
| Butalbital/acetaminophen/caffeine | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 8 | tablet; capsule | Generic drugs (ANDA) | May 1, 2024 |
| Bryant Ranch Prepack | 5 | capsule; tablet | Generic drugs (ANDA) | May 1, 2024 |
| Quagen Pharmaceuticals LLC | 5 | tablet; capsule | Generic drugs (ANDA) | May 1, 2024 |
| Actavis Pharma, Inc. | 4 | capsule; tablet | Generic drugs (ANDA) | July 29, 2013 |
| Advanced Rx of Tennessee, LLC | 4 | capsule; tablet | Generic drugs (ANDA) | January 8, 2026 |
| Amici Pharma, Inc. | 4 | tablet; capsule | Generic drugs (ANDA) | April 10, 2026 |
| Bryant Ranch Prepack | 4 | capsule; tablet | Generic drugs (ANDA) | December 17, 2019 |
| LGM Pharma Solutions, LLC | 4 | capsule; tablet | Generic drugs (ANDA) | October 18, 2021 |
| Lannett Company, Inc. | 4 | capsule; tablet | Generic drugs (ANDA) | December 17, 2019 |
| Granules Pharmaceuticals Inc. | 3 | capsule; tablet | Generic drugs (ANDA) | June 29, 2022 |
| Larken Laboratories, Inc. | 3 | tablet | Generic drugs (ANDA) | December 4, 2015 |
| Preferred Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | June 9, 2026 |
| Remedyrepack Inc. | 3 | tablet | Generic drugs (ANDA) | April 16, 2026 |
| A-S Medication Solutions | 2 | tablet | Generic drugs (ANDA) | March 5, 2019 |
| Breckenridge Pharmaceutical, Inc. | 2 | capsule | Generic drugs (ANDA) | May 1, 2009 |
| Burel Pharmaceuticals, LLC | 2 | tablet | Generic drugs (ANDA) | December 1, 2022 |
| Chartwell RX, LLC | 2 | capsule; tablet | Generic drugs (ANDA) | January 21, 1987 |
| Direct_Rx | 2 | tablet | Generic drugs (ANDA) | January 2, 2025 |
| Dr. Reddy's Laboratories Inc. | 2 | capsule | Generic drugs (ANDA) | September 1, 2024 |
| Hikma Pharmaceuticals USA Inc. | 2 | capsule | Generic drugs (ANDA) | May 9, 2022 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | March 5, 2019 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | September 13, 2012 |
| Seton Pharmaceuticals | 2 | capsule | Generic drugs (ANDA) | March 2, 2022 |
| Westminster Pharmaceuticals, LLC | 2 | capsule; tablet | Generic drugs (ANDA) | October 24, 2025 |
| Aarkish Pharmaceuticals NJ Inc. | 1 | tablet | Generic drugs (ANDA) | December 3, 2024 |
| Actavis Pharma, Inc. | 1 | capsule | Generic drugs (ANDA) | July 29, 2013 |
| Amneal Pharmaceuticals NY LLC | 1 | capsule | Generic drugs (ANDA) | April 1, 2019 |
| Asclemed USA, Inc. | 1 | tablet | Generic drugs (ANDA) | March 5, 2019 |
| Aurolife Pharma, LLC | 1 | capsule | Generic drugs (ANDA) | April 26, 2017 |
| AvKARE | 1 | capsule | Generic drugs (ANDA) | November 24, 2014 |
| AvPAK | 1 | tablet | Generic drugs (ANDA) | August 11, 2022 |
| Cardinal Health 107, LLC | 1 | tablet | Generic drugs (ANDA) | September 13, 2012 |
| El Dorado Distributors LLC | 1 | tablet | Generic drugs (ANDA) | October 10, 2013 |
| Genus Lifesciences | 1 | solution | Generic drugs (ANDA) | July 1, 2025 |
| Golden State Medical Supply, Inc. | 1 | tablet | Generic drugs (ANDA) | December 1, 2008 |
| Hawaii Repack, Inc. | 1 | tablet | Generic drugs (ANDA) | March 5, 2019 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 1 | injection | Generic drugs (ANDA) | December 12, 2024 |
| KVK-Tech, Inc. | 1 | tablet | Generic drugs (ANDA) | September 26, 2018 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | September 13, 2012 |
| Mikart, LLC | 1 | tablet | Generic drugs (ANDA) | January 21, 1987 |
| NuCare Pharmaceuticals,Inc. | 1 | tablet | Generic drugs (ANDA) | September 13, 2012 |
| Oceanside Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | June 19, 2017 |
| Onesource Specialty Pharma Limited | 1 | injection | Generic drugs (ANDA) | January 24, 2026 |
| Par Health USA, LLC | 1 | injection, powder, lyophilized, for solution | New drug applications (NDA) | November 1, 2007 |
| Par Health USA, LLC | 1 | tablet | Generic drugs (ANDA) | June 3, 1999 |
| Redpharm Drug | 1 | tablet | Generic drugs (ANDA) | September 26, 2018 |
| Sandoz Inc | 1 | capsule | Generic drugs (ANDA) | September 3, 2024 |
| Solco Healthcare US, LLC | 1 | capsule | Generic drugs (ANDA) | December 5, 2023 |
| St. Mary's Medical Park Pharmacy | 1 | tablet | Generic drugs (ANDA) | June 29, 2022 |
| Sun Pharmaceutical Industries, Inc. | 1 | capsule | Generic drugs (ANDA) | July 1, 2020 |
| Sunrise Pharmaceutical, Inc. | 1 | capsule | Generic drugs (ANDA) | January 10, 2017 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 57 | 55.3% |
| Capsule | 42 | 40.8% |
| Injection | 2 | 1.9% |
| Solution | 1 | 1% |
| Injection, powder, lyophilized, for solution | 1 | 1% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.